Vaishali Pharma Limited (NSE: VAISHALI), ISIN INE972X01022 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
VAISHALI last traded at ₹7.48 (+1.22%), with a 52-week range of ₹4.75 to ₹13.10 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 31.61%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 44/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.